Guardant HealthMEX:GH +24.52%13 Current Ratio is 4.68 as of Mar. 2026, which is 31% below its 10-year median of 6.75. GuruFocus rates MEX:GH with a GF Score™ of 13/100 and a GF Value™ of MXN1,048.04 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 214 Medical Diagnostics & Research companies, Guardant Health ranks better than 84.11% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Guardant Health's current ratio for the quarter that ended in Mar. 2026 was 4.68.
Guardant Health has a current ratio of 4.68. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Guardant Health's Current Ratio or its related term are showing as below:
MEX:GH'
s Current Ratio Range Over the Past 10 Years
Min: 3.5 Med: 6.75 Max: 28.27
Current: 4.68
During the past 10 years, Guardant Health's highest Current Ratio was 28.27. The lowest was 3.50. And the median was 6.75.
MEX:GH's Current Ratio is ranked better than 84.11% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: 1.99
vs MEX:GH: 4.68
Guardant Health (MEX:GH) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Guardant Health Current Ratio Related Terms
Guardant Health Current Ratio Historical Data
* Premium members only.
The historical data trend for Guardant Health's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Guardant Health's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guardant Health Current Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Guardant Health's Current Ratio distribution charts can be found below:
* The bar in red indicates where Guardant Health's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardant Health (MEX:GH) has a Current Ratio of 4.68 as of Mar. 2026. This is 31% below median its historical median of 6.75. Over the past decade, Guardant Health's Current Ratio has ranged from 3.50 to 28.27. According to the industry distribution chart, Guardant Health ranks #34 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 15.9%.
Is Guardant Health's Current Ratio too high?
Guardant Health's current Current Ratio of 4.68 is 31% below median its 10-year median of 6.75. Over the past 10 years, this metric has ranged from a low of 3.50 to a high of 28.27. The Medical Diagnostics & Research industry median Current Ratio is 1.99. Guardant Health's value of 4.68 is 135.2% above this industry median. Based on the distribution chart, Guardant Health ranks #34 out of 214 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Guardant Health has a GF Score™ of 13/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guardant Health's Current Ratio compare to LH and DGX?
According to the Medical Diagnostics & Research industry distribution chart, Guardant Health ranks #34 out of 214 companies for Current Ratio. This places Guardant Health in the top 16% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.99. Guardant Health's value of 4.68 is 135.2% above this benchmark. Historically, Guardant Health's own Current Ratio has ranged from 3.50 to 28.27 over the past decade. While the company's 10-year median is 6.75 vs. the industry median of 1.99, Guardant Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Diagnostics & Research company?
The median Current Ratio among Medical Diagnostics & Research companies is 1.99, based on 214 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guardant Health's current Current Ratio of 4.68 is 135.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median Current Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guardant Health's current Current Ratio is 4.68, which is 31% below median its own 10-year median of 6.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardant Health stock overvalued right now?
Based on GuruFocus' analysis, Guardant Health (MEX:GH) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN1,048.04, compared to a current price of MXN2,590.00 — trading 147.1% above its estimated fair value. The current Current Ratio is 4.68, which is 31% below median its 10-year median of 6.75 and 135.2% above the Medical Diagnostics & Research industry median of 1.99. Guardant Health's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Guardant Health (MEX:GH), the current Current Ratio is 4.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guardant Health (MEX:GH) Overvalued in 2026?
Based on GuruFocus' analysis, Guardant Health stock appears to be overvalued.
The current stock price of MXN2,590.00 is trading 147.1% above its estimated GF Value™ of MXN1,048.04.
GuruFocus considers Guardant Health to be Significantly Overvalued.
Key valuation signals for MEX:GH:
Current Ratio: 4.68 (31% below median its 10-year median of 6.75)
GF Value™: MXN1,048.04 vs. price of MXN2,590.00 (147.1% above fair value)
Industry Position: 135.2% above the Medical Diagnostics & Research median (#34 of 214)
No single metric tells the full story. See the MEX:GH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
13GF Score
Get the complete analysis for MEX:GH
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GH has been successfully added to your 
